VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Jiangsu Aidea Pharmaceutical Receives NMPA Approval for Darunavir API
Jiangsu Aidea Pharmaceutical Receives NMPA Approval for Darunavir API
May 24, 2026 15:39 CST Updated 15:57
Share: